Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JYB1904 in Allergic Asthma
NCT06438757Phase 2Completed
- Sponsor
- Jemincare
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ozureprubart in allergic asthma, sponsored by Jemincare. Started Jun 2024; status: completed.
02
Drugs
ozureprubart
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT06438757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06438757.